Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

AstraZeneca Sourcing Seroquel API in China

publication date: Oct 22, 2007

As part of its move to begin sourcing its APIs in China, AstraZeneca announced it would begin purchasing Lactam, a key chemical ingredient used to make Seroquel, its atypical schizophrenia drug, from contract manufacturers in China. Seroquel, which has patent protection until 2011, produced revenues of $3.4 in 2006. AstraZeneca has set a goal for itself to reduce its production expenses by $900 million in three years. More details...

Stock Symbols: (NYSE: AZN)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital